Abstract:Abstract Background: Aberrant splicing is a hallmark of cancer. For MYC-driven cancers, such as triple-negative breast cancer, hypersensitivity to spliceosome-targeted therapy is a novel anticancer strategy since it also triggers antitumorimmunity. Of the approximately 200 known spliceosomal genes, core spliceosomes are essential for cancer cell survival, yet the underlying mechanisms remain elusive. Methods: First, SNPRE representing the core spliceosomal Sm gene was screened using a multiomics database analysis approach. Then, we investigated the effect of SNRPE on the growth of TNBC cells in vitro and in vivo. We identified DDX20 from the interacting partners of SNPRE as a potential molecule involved in spliceosome vulnerability using coimmunoprecipitationtechniques. The mechanism of the SNRPE-DDX20 axis in tumor spliceosome therapeutic vulnerability was determined by various techniques,including RNA-seq, chromatin immunoprecipitation and other technologies. Results: In our research, SNRPE was upregulated in TNBC and predicted poor prognosis. Downregulation of SNRPE attenuated the vitality of TNBC in vivo and in vitro. We hypothesized and confirmed DDX20 as an important factor in core spliceosome therapeutic vulnerability. In DDX20-knockout TNBC cells, cell survival is no longer dependent onintracellular splicing activity orSNPRE expression. In DDX20/SNRPE double-downregulated cells, growth ability was restored due to MTOR reactivation via a splicing-independent pathway. In SNRPE-knockdown TNBC cells, ETV3 and its corepressor DDX20 function together to block MTOR expression to induce growth suppression. Once SNRPE expression was high, ETV3 bound to the C-terminus of DDX20 was replaced by SNRPE-containing components, whilethe binding affinity of released ETV3 to MTOR was reduced, and eventually, MTOR was expressed sufficiently to promote proliferation. Conclusions: Our results reveal that DDX20 is an adaptor in the crosstalk between RNA splicing (SnRNP components such as SNRPE) and the MTOR pathway in MYC-driven TNBC. Patients with high DDX20 expression are likely suitable for treatment with spliceosome modulators, leading to double killing effects by cell arrest and antitumorimmunity. Targeting DDX20 may serve as a therapeutic target for MYC-driven cancers.

RXXPEG Motif of MERIT40 is Required to Maintain Spindle Structure and Function Through Its Interaction with Tankyrase1

Regulation of A Dynamic Interaction Between Two Microtubule-Binding Proteins, Eb1 and Tip150, by the Mitotic P300/Cbp-Associated Factor (pcaf) Orchestrates Kinetochore Microtubule Plasticity and Chromosome Stability During Mitosis

The deubiquitinating enzyme complex BRISC is required for proper mitotic spindle assembly in mammalian cells

MERIT 40 Controls BRCA 1 – Rap 80 Complex Integrity and Recruitment to DNA Double-Strand Breaks

Merit40 Facilitates Brca1 Localization and Dna Damage Repair

Mps1 Dimerization and Multisite Interactions with Ndc80 Complex Enable Responsive Spindle Assembly Checkpoint Signaling

Reversible phosphorylation of Rpn1 regulates 26S proteasome assembly and function

Ubiquitin Ligase RNF20/40 Facilitates Spindle Assembly and Promotes Breast Carcinogenesis Through Stabilizing Motor Protein Eg5

MERIT, a cellular system coordinating lysosomal repair, removal and replacement

The deubiquitinating enzyme complex BRISC regulates Aurora B activation via lysine-63-linked ubiquitination in mitosis

Tankyrase1-mediated Poly(adp-Ribosyl)ation of TRF1 Maintains Cell Survival after Telomeric DNA Damage.

Mitotic Phosphorylation of TREX1 C Terminus Disrupts TREX1 Regulation of the Oligosaccharyltransferase Complex

WWOX binds MERIT40 and modulates its function in homologous recombination, implications in breast cancer

CCDC69 maintains genome integrity by regulating KIF2C/MCAK depolymerase activity and the stability of the chromosomal passenger complex

BubR1 Phosphorylates CENP-E As a Switch Enabling the Transition from Lateral Association to End-on Capture of Spindle Microtubules

Mitosis-specific MRN Complex Promotes a Mitotic Signaling Cascade to Regulate Spindle Dynamics and Chromosome Segregation

TRIM37 employs peptide motif recognition and substrate-dependent oligomerization to prevent ectopic spindle pole assembly

DDX20 interlinking with SNRPE endows MYC-driven triple-negative breast cancer therapeutic vulnerability in a splicing-independent manner

Mesoscale regulation of MTOCs by the E3 ligase TRIM37

Centromere protection requires strict mitotic inactivation of the Bloom syndrome helicase complex

Aurora kinase A-mediated phosphorylation triggers structural alteration of Rab1A to enhance ER complexity during mitosis